HIGHFIELD SURGERY
HOLTDALE APPROACH, LEEDS
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 143 | 159 | 89.9% | |
| CKD 4 | 2008 | 150 | 177 | 84.7% | |
| CKD 5 | 2009 | 30 | 35 | 85.7% | |
| CKD 5 | 2010 | 15 | 15 | 100.0% | |
| CKD 5 | 2011 | 13 | 13 | 100.0% | |
| CKD 5 | 2012 | 12 | 14 | 85.7% | |
| CKD 5 | 2013 | 8 | 9 | 88.9% | |
| CKD003 | 2014 | 12 | 13 | 92.3% | |
| CKD003 | 2015 | 12 | 12 | 100.0% | |
| NM84 | 2016 | 16 | 23 | 69.6% | |
| NM84 | 2017 | 16 | 22 | 72.7% | |
| NM84 | 2018 | 17 | 24 | 70.8% | |
| NM84 | 2019 | 27 | 31 | 87.1% | |
| NM84 | 2020 | 19 | 25 | 76.0% | |
| NM84 | 2022 | 28 | 36 | 77.8% | |
| NM84 | 2023 | 29 | 36 | 80.6% |
